Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria | MicrobiomeTrials← Back to trialsNCT02579044
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
ENROLLING_BY_INVITATIONPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2015-12Est. Completion: 2027-03
Enrollment target: 80 participants Locations- Boston Children's Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Hutchinson-Gilford Progeria Syndrome
This study aims to establish induced pluripotent stem cell (iPSC) lines from the blood of one pediatric patient with Hut…
Multiple LocationsEst. completion Dec 2026
Lipodystrophy
Human lipodystrophies (lipoD) represent a heterogeneous group of diseases characterized by generalized or partial fat lo…
Bordeaux, FranceCompleted Jan 2014